The advent of the CRISPR/Cas9 system has transformed field human genome engineering and created new perspectives in development innovative cell therapies. However, absence a simple, fast efficient delivery method into primary cells been limiting progress CRISPR/Cas9-based Here, we describe an optimized protocol for iTOP-mediated various cells, including T induced pluripotent stem (hiPSCs), Jurk...